Wuxi Apptec Co., Ltd. is a global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization) providing integrated drug discovery, development, and manufacturing services. The company operates through three main business segments: WuXi Chemistry, which offers CRDMO services for new drug development from discovery to commercial manufacturing; WuXi Biology, which provides a full spectrum of biology services and solutions; and WuXi Testing, which offers an integrated testing platform across the full life cycle of discovery and development. The company serves customers in the pharmaceutical and life sciences industries across Asia, Europe, and North America. Established in December 2000, the company was formerly known as WuXi PharmaTech Co., Ltd. It provides end-to-end capabilities to support partners in bringing treatments to patients globally.

Summarised from the company's own disclosures, fiscal year ended Apr 2026

Industry Drug Manufacturers - Specialty & Generic Homepage wuxiapptec.com
Sector Healthcare IR page wuxiapptec.com/investors
Tags
crdmo, drug discovery, drug development, pharmaceutical manufacturing, biology services, pharmaceutical testing, new drug development, life sciences, WuXi Chemistry, WuXi Biology, WuXi Testing
Press page wuxiapptec.com/investors/announcement/announcements

Metrics

Valuation  
Market cap HK$ 538.056B
Market cap (USD) $ 68.571B
P/E 24.92
PEG 0.93
P/BV 5.45
P/S 8.81
P/OCF 24.49
P/FCF —
Dividend yield 1.3%
Turnover / mcap 0.12%
Returns  
ROE 25.9%
ROI 19.5%
ROIC 23.6%
Profit margin 41.5%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) 26.9%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity 7.4%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 17
Quality score 22.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Revenue 43.421B 37.918B 40.341B 39.355B 22.902B 16.535B 12.872B 9.614B 7.765B
Net profit 18.023B 11.298B 10.69B 8.814B 5.097B 2.96B 1.855B 2.261B 1.227B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Share price 106.91 51.53 68.05 66.71 97.67 135.77 83.04 58.81 —
Price performance 12m 1.12 -0.24 -0.04 -0.35 -0.23 0.64 0.37 — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Wuxi Apptec Co., Ltd. (ticker 2359), listed in Hong Kong.

ETFs Holding Wuxi Apptec Co., Ltd.

ETF Weight in ETF Shares Market value As of
EXUS 2.12% 102,942 $ 2.017M Jun 30, 2026
ASIA 0.85% 24,300 $ 476.267K Jun 30, 2026
FFEM 0.82% 24,946 $ 511.173K Jul 31, 2026
TDI 0.62% 114,800 $ 2.25M Jun 30, 2026
CGXU 0.52% 1,371,100 $ 33.115M Nov 16, 2026
EMMF 0.46% 41,700 $ 817.298K Jun 30, 2026
DEHP 0.32% 50,200 $ 1.289M Nov 12, 2026
FFGX 0.31% 8,161 $ 167.228K Jul 31, 2026
REMG 0.29% 15,600 $ 305.721K Jun 30, 2026
CGNG 0.24% 294,400 $ 7.11M Nov 16, 2026
SEEM 0.20% 62,400 $ 1.223M Jun 30, 2026
DFSE 0.15% 34,700 $ 890.872K Nov 12, 2026
NTSE 0.10% 2,940 $ 57.622K Jun 30, 2026
AVSE 0.09% 7,900 $ 188.611K Nov 16, 2026
DFAE 0.08% 299,200 $ 7.682M Nov 12, 2026
AVEM 0.08% 862,104 $ 20.583M Nov 16, 2026
DFEM 0.07% 252,800 $ 6.49M Nov 12, 2026
DFAX 0.04% 204,580 $ 5.252M Nov 12, 2026